--- Chain 16 for Question 102 ---
Status: USED_FOR_VOTING
Finish Reason (Model): stop
Extracted Answer: D
Prompt Tokens (Usage): 439
Completion Tokens (Usage): 8107
Reasoning Tokens (Counted): 7241
Non-Reasoning Tokens (Counted): 864
Total Tokens (Usage): N/A

--- Reasoning Content ---
Okay, so I've got this question about a genetic construct and why the GFP isn't showing up in the mice. Let me try to unpack this step by step.

First, the setup: They've created a bicistronic vector using lox-Cre technology. That means the vector has two open-reading frames (ORFs), right? One for the ligand and the other for the receptor. The ligand is at the 5' end, fused to mCherry, and the receptor is at the 3' end with eGFP at the C-terminus. So the vector is like: ligand (CBA promoter) -> IRES -> receptor (with their own promoter? Or is the IRES the only thing separating them?) Wait, the way it's described, the ligand is under the CBA promoter, and upstream of the receptor is the IRES element. Hmm, maybe I'm getting that backwards.

Wait, bicistronic vectors typically have two genes under the control of a single promoter but with an IRES element separating them. So the first gene is under the promoter, then IRES, then the second gene. But in this case, the ligand is under CBA promoter, and the receptor is after the IRES. So the vector would be: Promoter (CBA) -> Ligand ORF -> IRES -> Receptor ORF -> eGFP. Or is the IRES before the receptor?

Wait, the question says: the ligand ORF is 5' and fused to mCherry; the receptor is 3' and eGFP. Between ligand and mCherry is a stop in a loxP cassette. Between receptor and eGFP is a stop in lox2272. So, the initial vector is probably set up so that without Cre, the ligand is expressed along with mCherry, and the receptor is not expressed because of the stop cassette. Or maybe it's the other way around.

Wait, bicistronic vectors often have two cassettes. Each ORF is flanked by stop signals, so without Cre, only one ORF is expressed. Depending on the loxP sites, Cre can excise the stop cassettes and allow expression of both ORFs.

Wait, the ligand is under the CBA promoter. The ligand is fused to mCherry. But the ligand's ORF is followed by a stop in a loxP cassette. So the setup is: CBA promoter drives the ligand ORF, which is followed by loxP-stop-loxP. Then, beyond that, there's an IRES, then the receptor ORF, which is followed by lox2272-stop-lox2272. So, without Cre, the ligand would be expressed because the stop cassette is in the way for the receptor, but wait, how does the IRES factor in?

Wait, in bicistronic vectors, the IRES allows for internal ribosome entry, so both ORFs can be translated from a single mRNA. But if there's a stop cassette, maybe that disrupts this. I'm a bit confused. Let me think again.

The vector is bicistronic, meaning two ORFs in one transcript. The first ORF is ligand, followed by a stop cassette (loxP-stop-loxP). Then comes the IRES, and then the receptor ORF, followed by a stop cassette (lox2272-stop-lox2272). So, for the vector without Cre, the first stop cassette after ligand would terminate translation, and the IRES might not function because the stop is in place. Or maybe the IRES allows the second ORF to be read through.

Wait, the loxP and lox2272 are different sites, so when you have Cre, it would only excise the stop cassettes that match. So, for the ligand, the loxP stop cassette is between the ligand and mCherry. Wait, no, the ligand is fused to mCherry. Wait, the ligand ORF is fused to mCherry, so perhaps the ligand and mCherry are in the same ORF. No, wait, the ligand is at 5', so the ORF is ligand followed by mCherry. Oh wait, no, the ligand is fused to mCherry, so they're in the same ORF. Oh wait, no, the vector is bicistronic, so they're two separate ORFs.

Wait, maybe not. Let's clarify:

The ligand ORF is at the 5' position, fused to mCherry. So, the ligand is expressed as a fusion protein with mCherry. So that's one ORF: ligand-mCherry. Then, the receptor ORF is at the 3' end, fused to eGFP. So receptor-eGFP is another ORF. Each is separated by an IRES or something else.

Wait, perhaps the vector is set up so that the ligand and mCherry are in one ORF, followed by a stop cassette. Then, after the IRES, the receptor and eGFP are in another ORF, followed by another stop cassette.

So, when Cre isn't present, the stop cassettes prevent expression of both ORFs. Or maybe the ligand ORF is under a promoter, and the receptor is under IRES. Wait, the ligand is under the CBA promoter. The CBA promoter is a strong promoter, so the ligand should be expressed. But the ligand is fused to mCherry, so they're in the same ORF. Then, after the ligand, there's a stop in a loxP cassette. So, without Cre, the ligand-mCherry is expressed, and the receptor-eGFP is not, because the lox2272 stop is in place. Because Cre would excise the stop cassettes only if the appropriate lox sites are present.

Wait, but the question says that after transfecting the plasmid into primary astrocyte culture, they used antibodies against the overexpressed proteins. So presumably, the ligand and receptor were being expressed. But in the mouse model, they're using a Cre line.

They made a mouse homozygous for the construct in a wild-type background. Then crossed to SOX10-Cre hemizygous mice. So, SOX10 is expressed in neural crest cells, which is where the ligand and receptor are initially expressed. The idea is that Cre would excise the stop cassettes, allowing both ligand and receptor to be expressed.

Wait, but the vector's setup: the ligand is under CBA promoter, then the ligand ORF is followed by a loxP-stop-loxP cassette. Then, the IRES, then the receptor ORF with a lox2272-stop-lox2272 before eGFP.

So, when Cre is present, it would excise the stop cassettes. But loxP and lox2272 are different sites. The Cre used is the loxP Cre, right? Because SOX10-Cre is a Cre line that probably uses the loxP sites.

So, when Cre is expressed, it would excise the loxP-stop-loxP cassette, allowing the ligand and mCherry to be expressed. But what about the receptor? The receptor is after the IRES, followed by a lox2272 stop cassette. So, if Cre is loxP-based, it won't excise the lox2272 stop. So the receptor-eGFP would remain under a stop cassette. So the receptor wouldn't be expressed.

Wait, that can't be right, because both the ligand and the receptor are supposed to be expressed in the neural crest cells. So maybe the stop cassettes are designed such that Cre would excise both. Alternatively, perhaps the vector is set up with the same lox sites. I'm getting a bit confused here.

Wait, maybe the vector has the ligand followed by a loxP-stop, and the receptor followed by a lox2272-stop. So, when Cre is introduced (which is usually loxP-based), it would excise the loxP-stop, but not the lox2272. So the ligand would be expressed, but the receptor wouldn't, because the lox2272 stop remains. Alternatively, perhaps the vector is designed so that both stops are the same. But the question states that the ligand has a loxP stop and the receptor a lox2272 stop.

So SOX10-Cre would only excise the loxP stops, not the lox2272. So, in the mouse, the ligand-eGFP (no, wait, ligand is fused to mCherry) would be expressed, but the receptor-eGFP would not because the lox2272 stop remains. So in the offspring, when they look for eGFP, it's only from the receptor. So they're not seeing any green signal because the receptor-eGFP isn't expressed.

Wait, but why would they only look for eGFP? Because the ligand is fused to mCherry, which is a red fluorescent protein. So the eGFP is only on the receptor.

So when they crossed to SOX10-Cre, which is a Cre line, the Cre would excise the loxP-stop, allowing the ligand-mCherry to be expressed. But the receptor would still have the lox2272 stop, which isn't excised, so receptor-eGFP isn't expressed. So when they look for GFP, nothing shows up.

But why did they use a bicistronic vector with both stops? Maybe the idea was that the Cre would excise both stops, but if they're different, that's not possible.

Alternatively, perhaps the vector is set up differently. Let me think again. The ligand is under the CBA promoter, followed by the ligand ORF, then a loxP-stop-loxP. Then comes the IRES, then the receptor ORF, followed by a lox2272-stop-lox2272. So, in the absence of Cre, the ligand ORF is expressed (because the promoter is active), but the stop after ligand prevents the IRES from working. So only ligand-mCherry is expressed. When Cre is present, it's supposed to excise both stops.

Wait, no, because the lox sites are different. So only the loxP stop would be excised. The ligand is expressed, but the receptor isn't, because the lox2272 stop remains.

Wait, but the question says that when they transfected the plasmid into astrocytes, they used antibodies against the overexpressed proteins. So presumably, in the plasmid transfection, the ligand and receptor were both expressed. But in the mouse, they only get ligand because the receptor is not expressed.

So when they cross the homozygous construct with SOX10-Cre, only the loxP stop is removed, allowing the ligand to be expressed. The receptor's stop isn't removed because it's a different site (lox2272), so receptor-eGFP isn't expressed. Hence, no green signal in the confocal.

So, why would the eGFP not be expressed? Because the stop wasn't excised. So the issue is that the lox2272 stop remains. Therefore, the receptor-eGFP isn't expressed.

Looking at the options:

Option D says the receptor and eGFP are not in the frame. Wait, if the stop remains, the ORF isn't read through, so the eGFP wouldn't be expressed. But the problem is whether the stop is removed. So, the issue is that the stop wasn't excised, not a frame issue.

Option B says the receptor-eGFP is stuck in the Golgi. That would affect trafficking but not expression. If the receptor is made, it might not get to the surface, but the Western blot would show the protein. Since they didn't observe a green signal in the confocal, which looks for GFP in the cells. But if the protein is made but stuck in the Golgi, there would be a band on Western, which they tested before.

Wait, the setup says that after transfection, they used antibodies against the overexpressed proteins and ran a Western blot. So they probably saw both ligand and receptor on the blot. So in the mouse model, perhaps the issue is that the Cre didn't excise the stop, so receptor isn't expressed. Or maybe the promoter is wrong.

Looking back, the ligand is under CBA promoter. The receptor is after the IRES. Maybe the promoter is only driving the ligand, and the IRES is supposed to allow the receptor to be expressed. But if the stop cassette is in place, the IRES isn't functional. So without Cre, the receptor isn't expressed. But in the mouse, Cre is present, which should excise the loxP stop, allowing the IRES to function and the receptor to be expressed.

Wait, but if the vector is set up so that the ligand and the receptor are both under the same promoter (CBA), but separated by an IRES, then the IRES allows the receptor to be expressed in the same transcript. But in this setup, the ligand is followed by a stop, so without Cre, the receptor isn't expressed. With Cre, the stop is removed, so the IRES can function and the receptor is expressed.

But in the mouse, why isn't the receptor expressed?

Wait, the stop between ligand and IRES is a loxP stop. Cre would excise this, removing the stop, allowing the IRES to function. Then, the receptor ORF would be translated, and the eGFP would be part of that. But the stop after the receptor is a lox2272 stop. So unless the Cre can also excise that, the receptor-eGFP would still have a stop.

But SOX10-Cre is a standard Cre line that uses loxP sites. It can't excise lox2272 cassettes. So the stop after the receptor remains, preventing expression of the receptor-eGFP. Hence, the eGFP isn't expressed.

So, when they look for eGFP in the offspring, it's not present because the stop isn't excised, so the receptor isn't expressed. That explains why no green signal.

Looking at the options:

Option D: receptor and eGFP not in frame. That would mean a frameshift, but the question says the ORF is fused, so probably in frame.

Option B: stuck in Golgi. But then the Western blot should show the protein. Since the question says they used the antibodies after transfecting into astrocytes, I'm assuming the Western worked, so the construct is functional.

Option C: enhancer missing. That would affect expression, but the ligand and receptor would both rely on the same enhancer. But in the Western, both would be expressed. But in the mouse, only the ligand is expressed, which would require that the enhancer is present.

Wait, the enhancer for expression is probably in the CBA promoter. So if the enhancer was missing, neither protein would be expressed, but in the transfection, they saw expression. So probably not.

Option A: ligand and receptor are paracrine. That means they act on different cells. But the question is about expression in the same cells. So if they're paracrine, maybe the ligand is expressed in one cell, the receptor in another. But the setup uses the same construct, so both should be expressed in the same cells. But perhaps in the mouse, the Cre isn't active in the right cells, but the question says they crossed with SOX10-Cre, which is active in neural crest cells.

Wait, but the issue is that the receptor isn't expressed because the stop isn't excised. So the correct answer would relate to the stop cassette not being removed.

So, the possible options are D and B and C. Let me think again:

If the stop isn't removed, the receptor isn't expressed. So why isn't the stop removed? Because the Cre can't excise it. Because the stop is in a lox2272 cassette, and the Cre is loxP-based. So that's the problem.

But none of the options directly state this. Let me look at the options again.

Option D: the receptor and eGFP are not in the frame. That would mean the ORF is interrupted, but the stop is due to a stop cassette, not a frameshift.

Option B: the receptor-eGFP construct is stuck in the Golgi. If the protein is made but not secreted, but Western blot would show it.

Another thought: in the vector, the ligand is fused to mCherry, and the receptor to eGFP. So, in the mouse, the Cre should excise the loxP stop, allowing the IRES to function, then the receptor-eGFP is expressed.

But if the vector's IRES is not functional, the receptor won't be expressed. But IRES elements are usually cell-type specific. If the cells don't support the IRES, then the receptor isn't expressed even if the stop is excised.

But the question says that the ligand and receptor are initially expressed in neural crest cells, so the IRES should function there. So that shouldn't be the issue.

Hmm. So the only other option is that the stop wasn't excised because the Cre can't do it. So the problem is that the lox2272 stop remains. But the answer options don't directly state that.

Wait, looking at the options again:

Option D says the receptor and eGFP are not in frame. If the lox2272 stop remains, the ORF is interrupted, so the eGFP isn't expressed. But the issue is that the stop remains, not a frame issue. The fusion would be in frame if the stop is removed.

So perhaps the reason is that the stop isn't removed, so the receptor isn't expressed. But none of the options directly address the stop. So perhaps the answer is D, but I'm not certain.

Wait, another approach: the vector is bicistronic with the ligand and receptor. The Cre is supposed to remove the stops so both are expressed. But in reality, only the ligand's stop is removed. So ligand is expressed, but the receptor's stop remains, so the receptor isn't. Thus, in the mouse, only ligand-mCherry is expressed, but not receptor-eGFP. But the question is why there's no green signal. So the answer is that eGFP isn't expressed because the stop isn't excised, which is because the Cre can't excise the lox2272 stop.

But none of the options directly state that. So I need to see which option aligns.

Option D says the receptor and eGFP are not in frame. If the stop is not removed, the ORF of the receptor is truncated, so the eGFP isn't expressed. But it's not a frame issue, it's a stop codon issue.

Wait, the stop cassette is a transcriptional stop, not a translational stop. Oh wait, in vectors, the loxP-stop-loxP is a transcriptional stop, meaning that without Cre, the downstream ORF isn't transcribed. So, if the stop isn't excised, that ORF isn't expressed. So, in the mouse, the receptor isn't being expressed because the stop isn't excised.

So, why isn't the stop excised? Because the lox sites are different. The ligand's stop is loxP, which Cre can excise. The receptor's stop is lox2272, which Cre can't. So the ligand is expressed, the receptor isn't.

So, the answer would be that the stop cassette for the receptor isn't excised, so the receptor isn't expressed. But the options don't say that. The closest option is D, but that's about frame.

Alternatively, perhaps the stop is in a different position. Let me re-examine the vector setup.

The ligand is at 5', with a loxP-stop-loxP between the ligand and mCherry. Wait, no, the ligand is fused to mCherry. So the ligand ORF is followed by a stop cassette. So, without Cre, the ligand-mCherry is expressed, and the receptor isn't. But when Cre is present, the ligand's stop is excised, allowing the IRES to function, so the receptor is expressed.

Wait, no. Because the ligand's ORF is followed by the stop. So with Cre, the stop is excised, allowing the IRES to function, so the receptor is expressed. But the receptor's ORF is followed by a lox2272 stop. So the eGFP is after the receptor. So, the Cre can't excise lox2272, so the eGFP isn't expressed.

Wait, that would mean that the receptor is expressed, but the eGFP isn't. Wait, but the eGFP is part of the receptor ORF. Oh no, the receptor is fused to eGFP, so the ORF is receptor-eGFP. So, the stop is after eGFP. So, the IRES is between the ligand and the receptor-eGFP. So, the setup is:

CBA promoter → ligand ORF (with mCherry) → loxP-stop → IRES → receptor ORF (with eGFP) → lox2272-stop.

So, without Cre, the ligand is expressed (since the promoter is active), but the receptor isn't. With Cre, the loxP stop is excised, allowing the IRES to function, so the receptor is expressed. But the lox2272 stop remains, so the eGFP is not part of the receptor ORF. Wait, no, the eGFP is part of the receptor ORF. So the stop is after the eGFP? Or before?

Wait, the question says: the receptor ORF is at the 3' end and fused to eGFP at the C-terminus. Between the receptor and eGFP is a stop in a lox2272 cassette. Wait, that's confusing. So the receptor is followed by a stop, then eGFP? Or the receptor is fused to eGFP, but there's a stop between them?

Wait, the question says: between the receptor and eGFP, there's a stop in the lox2272 cassette. Oh, so the receptor ORF is followed by a stop cassette. So, the setup is ligand (with mCherry) → stop (loxP) → IRES → receptor → stop (lox2272) → eGFP. No, that can't be right. Alternatively, the receptor is fused to eGFP, but between them is a stop.

Wait, perhaps the receptor is in a separate ORF. So:

Ligand ORF (with mCherry) is under the CBA promoter. Then, after the ligand, a stop in a loxP cassette. Then an IRES, then the receptor ORF, which is followed by a stop in a lox2272 cassette, and then eGFP.

Wait, that doesn't make sense. Because eGFP is at the C-terminus of the receptor.

Wait, perhaps it's ligand ORF (mCherry) followed by loxP stop. Then IRES, then receptor ORF (eGFP) followed by lox2272 stop. So, the eGFP is part of the receptor ORF.

So, without Cre, ligand-mCherry is expressed, receptor-eGFP isn't. With Cre, the loxP stop is excised, so the IRES allows the receptor-eGFP to be expressed, but the lox2272 stop remains, so eGFP isn't expressed? No, that can't be because the eGFP is part of the receptor ORF.

Wait, I'm getting stuck here. Let me think of the vector as:

Promoter (CBA) --> [Ligand ORF] --> [loxP-stop-loxP] --> IRES --> [Receptor ORF] --> [lox2272-stop-lox2272] --> [eGFP] ?

No, that doesn't make sense. The eGFP is fused to the receptor, so it's part of the same ORF. So the correct arrangement is:

CBA promoter → Ligand ORF (fused to mCherry) → loxP-stop → IRES → Receptor ORF (fused to eGFP) → lox2272-stop.

Wait, that can't be. Because the eGFP is part of the receptor ORF, so the ORF is Receptor-eGFP. So, the arrangement would be:

CBA promoter → Ligand-mCherry → loxP-stop → IRES → Receptor-eGFP → lox2272-stop.

So, when Cre is present, it excises the loxP-stop, allowing the IRES to function. So the Receptor-eGFP is expressed because the stop is removed. But the lox2272-stop is after the Receptor-eGFP. Wait, no, the Receptor-eGFP is followed by a stop. So even if the loxP is excised, the Receptor-eGFP is followed by a stop. So the stop after the Receptor-eGFP would prevent further expression. But the eGFP is part of the ORF, so the stop after it would truncate the mRNA.

Wait, I'm getting more confused. Maybe I should think about the options again.

The question states that after creating the construct, the mouse is homozygous for it. Then crossed to SOX10-Cre. The offspring don't show green (eGFP). The possible reasons are the options.

Option D says the Receptor and eGFP are not in frame. Which would mean the ORF is interrupted, leading to no eGFP expression. But that's a frameshift issue. However, the stop is due to the cassette, not a frameshift.

Option B is about the construct being stuck in the Golgi. But the Western blot should show the protein.

So, perhaps the correct answer is D, but I'm not sure. Alternatively, the issue is that the stop wasn't excised, but that's not an option.

Wait, another angle: the vector is designed so that without Cre, both ORFs are expressed because the stops are in place. But no, that's not how it works. The stops prevent the second ORF from being expressed.

Wait, perhaps the issue is that the IRES is not functional, so even if the stop is excised, the receptor isn't expressed. But the IRES is supposed to work in neural crest cells.

Alternatively, maybe the vector is designed such that both ORFs are only expressed when Cre is present, but in this case, only the ligand's stop is removed, not the receptor's.

Wait, but the question says that the vector is bicistronic, which means both are on the same transcript. So perhaps the IRES allows the receptor to be expressed after the ligand. But with the stops in place, the receptor isn't expressed unless the stop is excised.

In the mouse, the Cre is present, so the ligand's stop is excised, allowing the IRES to function. So the receptor is expressed, and the eGFP should be visible.

But the mouse shows no green. So why? Maybe the eGFP is not expressed because the stop after the receptor remains, but that would require that the stop is after the eGFP, which isn't the case.

Wait, the setup says the eGFP is at the C-terminus of the receptor. So the ORF is Receptor-eGFP. After that, there's a stop in a lox2272 cassette. So when Cre is present, it would excise the lox2272 stop, allowing eGFP to be expressed.

Wait, no, because the eGFP is part of the same ORF. So the stop is after the eGFP, which would terminate the ORF. So if the stop isn't excised, the eGFP wouldn't be part of the protein. So the Receptor-eGFP would be truncated at the stop, meaning eGFP isn't expressed. But Cre would excise the lox2272 stop, allowing the full ORF.

But if the Cre is loxP-based, it can't excise the lox2272 stop. So the eGFP stop remains, so the eGFP isn't expressed.

So, the reason is that the stop after the receptor isn't excised, so the eGFP isn't expressed. So the correct answer is that the stop wasn't excised because the Cre can't handle lox2272.

But the options don't have that. So looking back, the only option that relates is D, but it's about frame. Alternatively, perhaps the issue is that the eGFP isn't in frame, but I think it's more about the stop.

Wait, another thought: if the IRES is correctly working, but the receptor isn't in frame, perhaps the eGFP isn't expressed. But the question doesn't state anything about frame shifting.

Alternatively, perhaps the loxP and lox2272 stops are in the same orientation, leading to the eGFP not being expressed.

Hmm. I'm stuck. Let me think about the possible options again.

Option D says the receptor and eGFP are not in frame. If the orf is disrupted, eGFP wouldn't be expressed. So that could explain no green.

But why would the proteins not be in frame? The vector design fuses eGFP to the receptor, so that should be in frame.

Wait, unless the stop cassette is in between the receptor and eGFP, causing a frameshift. But the question says between the receptor and eGFP is the stop.

Ah, wait! If the vector is set up such that the receptor is followed by a stop (lox2272), and then eGFP, that's a problem. Because the stop would terminate the receptor ORF, making eGFP not part of the same protein. But the question says the receptor is fused to eGFP, so they should be in the same ORF.

Wait, perhaps the vector is:

Ligand (mCherry) → loxP-stop → IRES → Receptor (eGFP) → lox2272-stop.

So, the Receptor-eGFP is a single ORF. The stop after it is a transcriptional stop (in lox2272). So, when Cre is present, the lox2272 stop is excised, allowing the eGFP to be expressed. But if the Cre can't excise it, the stop remains.

But the Cre is loxP-based, so it won't excise the lox2272 stop. So the Receptor-eGFP remains under the stop, so the eGFP isn't expressed. Hence, no green signal.

But none of the options directly address this. So perhaps the correct answer is D, but I'm not entirely confident.

Alternatively, perhaps the issue is that the IRES isn't functional, but that doesn't explain why only the eGFP isn't expressed.

Wait, another angle: in the vector, the IRES is between the ligand and the receptor. So, when Cre excises the loxP stop, the IRES allows the receptor to be expressed. But the lox2272 stop is after the receptor. So, the eGFP is part of the receptor ORF, but the stop is after it. So without Cre, the stop is in place, and the receptor isn't expressed. With Cre, the loxP is excised, IRES works, but the lox2272 stop remains, so the eGFP isn't expressed either.

Wait, no. The eGFP is part of the receptor ORF. The stop is after the eGFP, so if the stop is present, the Receptor-eGFP isn't expressed. So unless the stop is excised, the eGFP isn't expressed.

So, the problem is that the lox2272 stop isn't excised, so the Receptor-eGFP isn't expressed. Thus, no eGFP.

But the answer options don't mention this. So perhaps the correct answer is D, but I'm not sure. Alternatively, perhaps the issue is that the eGFP is not in frame with the receptor, but that's not the case.

Wait, the question states that the receptor is a monomeric transmembrane protein, which is expressed correctly. So the vector should have the eGFP in frame.

Alternatively, perhaps the fusion of eGFP to the receptor caused a frameshift, but without knowing the exact sequences, it's hard to say.

I think the correct answer is D, but I'm not entirely certain. Alternatively, the answer is B if the protein is made but not secreted, but the Western blot would show it.

After considering all this, I think the most plausible answer is D: the Receptor and eGFP are not in the frame. But I'm not entirely confident. Alternatively, perhaps the stop wasn't excised, but that's not an option.


--- Final Answer Content ---


The question involves a bicistronic lox-Cre vector designed to express a ligand and receptor in neural crest cells. The ligand is fused to mCherry, and the receptor is fused to eGFP. The vector includes stop cassettes: a loxP-stop-loxP cassette between the ligand and mCherry, and a lox2272-stop-lox2272 cassette between the receptor and eGFP. The ligand is under the CBA promoter, and the receptor is separated from the ligand by an IRES element. The vector is introduced into mice homozygous for the construct, which are then crossed with SOX10-Cre hemizygous mice. Despite this, no green signal (eGFP) is observed in the offspring under confocal microscopy.

### Key Analysis:
1. **Vector Setup**:
   - The ligand ORF is under the CBA promoter and fused to mCherry. A loxP-stop-loxP cassette follows the ligand, preventing expression of the receptor unless Cre excises the stop.
   - The receptor ORF is positioned after the IRES element and is fused to eGFP. A lox2272-stop-lox2272 cassette follows the receptor, preventing expression of eGFP unless Cre excises the stop.

2. **Role of Cre**:
   - SOX10-Cre is a loxP Cre line, meaning it can excise loxP-stop-loxP cassettes but not lox2272-stop-lox2272 cassettes. Therefore, in the offspring, the loxP stop cassette is excised, allowing the IRES to function and the receptor to be expressed. However, the lox2272 stop cassette remains, preventing eGFP expression.

3. **Expression Outcomes**:
   - In the absence of Cre, the ligand-mCherry is expressed (due to the CBA promoter), but the receptor-eGFP is not (due to the loxP-stop cassette).
   - In the presence of SOX10-Cre, the loxP stop is excised, allowing the IRES to function and the receptor to be expressed. However, the lox2272 stop remains, preventing eGFP from being expressed as part of the receptor ORF.

4. **Western Blot and Confocal Results**:
   - After transfection into astrocytes, antibodies against overexpressed proteins were used, suggesting both ligand-mCherry and receptor-eGFP were expressed in vitro.
   - In the mouse offspring, no green signal (eGFP) is observed under confocal microscopy, indicating that the receptor-eGFP is not expressed in vivo.

5. **Option Analysis**:
   - **(A) Ligand and receptor are in a paracrine relationship**: This is incorrect because the vector is designed for co-expression of both proteins in the same cells, and the issue lies in the expression of eGFP, not their relationship.
   - **(B) The receptor-eGFP construct is stuck in the Golgi**: This is unlikely because the Western blot would still detect the receptor-eGFP protein, even if it were improperly trafficked.
   - **(C) The enhancer for the ligand and receptor expression is missing**: This is incorrect because the CBA promoter drives ligand expression, and the IRES allows receptor expression when the loxP stop is excised.
   - **(D) The receptor and eGFP are not in the frame**: This is the most plausible explanation. The lox2272 stop cassette prevents the full receptor-eGFP ORF from being expressed, effectively truncating the protein and preventing eGFP expression. This aligns with the observation of no green signal in the confocal microscopy.

### Conclusion:
The absence of the green signal is due to the receptor and eGFP not being in frame, likely caused by the remaining lox2272 stop cassette preventing full expression of the receptor-eGFP ORF. 

Answer: D